An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma
Clinical trial NCT07200375 · RECRUITING
Trial details
- NCT number
- NCT07200375
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-09-29
- Primary completion
- 2029-09-29
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.